
Consumers who received a notice from Octapharma Plasma Inc. informing them of an April 2024 data breach may have affected their personal information may qualify to claim up to $5,050 from a class action settlement.
Octapharma Plasma Inc. agreed to pay $2.55 million to resolve a class action lawsuit alleging Octapharma Plasma failed to implement adequate cybersecurity measures, resulting in unauthorized access to sensitive personal information, including:
- Names
- Dates of birth
- Social Security numbers
- Health data
- Donor eligibility information
Who can file an Octapharma Plasma claim?
Class members must meet the following criteria:
- They are a living individual.
- They currently live in the United States.
- They received a notice from Octapharma Plasma Inc. stating the data breach may have affected their personal information.
California residents as of April 17, 2024, are eligible for an additional statutory payment.
How much is the data breach payout?
The total settlement fund is $2,550,000. After deducting court-approved attorneys’ fees, service awards for class representatives and settlement administration costs, the settlement administrator will distribute the remaining funds to class members who submit valid claims.
- Documented losses: Up to $5,000 for out-of-pocket expenses or financial losses related to the data incident. Expenses another source already reimbursed are not eligible.
- Flat cash payment: Instead of documented losses, class members can claim a flat cash payment estimated to be $100. The actual amount may be higher or lower depending on the number of valid claims submitted and the total amount claimed.
- California statutory payment: An additional $50 for those who resided in California as of April 17, 2024
- Credit monitoring: All class members can elect to receive three years of credit monitoring, which includes real-time monitoring at all three credit bureaus, dark web scanning, public record monitoring, medical identity monitoring, identity theft insurance with no deductible and access to fraud resolution agents.
If the total amount claimed exceeds the available funds, the settlement administrator may reduce payments on a pro rata basis. If the total amount claimed is less than the available funds, the settlement administrator may increase payments on a pro rata basis.
How to claim a class action payment
Class members can file a claim online or download, print and complete the PDF claim form (beginning Page 97) and mail it to the settlement administrator. The claim deadline is Nov. 14, 2025.
Settlement administrator's mailing address: Woodall v. Octapharma Plasma Inc. Settlement Administrator, P.O. Box 301134, Los Angeles, CA 90030-1134
Is proof or documentation required to submit a claim?
- To file an online claim, class members must provide the claim ID and PIN located on their settlement notice.
- To claim documented losses, class members must provide reasonable documentation (e.g., bank statements, police reports receipts, etc.) showing out-of-pocket expenses or losses related to the data breach.
- To claim the flat cash payment, California payment or credit monitoring benefit, class members need only select the appropriate option on the claim form.
Payout options
- PayPal (online claims only)
- Venmo (online claims only)
- Paper check
$2.55 million settlement fund breakdown
- Settlement administration costs: To be determined
- Attorneys' fees: Up to $849,915
- Attorneys' expenses: To be determined
- Service awards to class representatives: Up to $2,500 each
- Credit monitoring costs: Dependent on number of valid claims
- Payments to eligible class members: The remainder of the fund
Important dates
- Exclusion deadline: Oct. 29, 2025
- Deadline to file a claim: Nov, 14, 2025
- Final approval hearing: Dec. 4, 2025
When is the Octapharma Plasma settlement payout date?
The settlement administrator will distribute payments approximately 60 days after the court grants final approval of the settlement and resolves any appeals.
Why did this class action settlement happen?
The class action lawsuit alleged Octapharma Plasma Inc. failed to implement adequate cybersecurity measures, resulting in unauthorized access to sensitive personal information. The plaintiffs claimed this led to risks of identity theft and other harms.
Octapharma denied any wrongdoing but agreed to settle to avoid the risks and costs of further litigation.
Comments